+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Tumor"

Carcinoid Tumor Market - Product Thumbnail Image

Carcinoid Tumor Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
From
Oncology Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Oncology Collaboration and Licensing Deals 2019-2024

  • Report
  • October 2024
  • 1800 Pages
  • Global
From
From
From
From
From
From
Bispecific Molecules in Oncology: Analytical Tool - Product Thumbnail Image

Bispecific Molecules in Oncology: Analytical Tool

  • Report
  • January 2025
  • Global
From
From
From
Oncology Ablation Market Report 2024 - Product Thumbnail Image

Oncology Ablation Market Report 2024

  • Report
  • October 2024
  • 175 Pages
  • Global
From
Loading Indicator

The tumor market within the context of oncology is a rapidly growing sector of the healthcare industry. It is focused on the diagnosis, treatment, and prevention of cancer. This market includes a wide range of products and services, such as drugs, medical devices, diagnostics, and imaging technologies. It also includes services such as radiation therapy, chemotherapy, and immunotherapy. The tumor market is driven by the increasing prevalence of cancer, advances in technology, and the development of new treatments. It is also driven by the increasing demand for personalized medicine and the need for better patient outcomes. The tumor market is highly competitive, with many companies competing for market share. Some of the major players in the market include Roche, Novartis, Merck, AstraZeneca, Pfizer, and Bristol-Myers Squibb. Other companies in the market include AbbVie, Amgen, Celgene, Eli Lilly, and GlaxoSmithKline. Show Less Read more